drugset / Trial / NCT05113888

Exploratory Study on Dosage of Qizhi Weitong Granules in the Treatment of Irritable Bowel Syndrome (IBS)

NCT05113888

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study are as follows: 1) To evaluate the efficacy and safety of Qizhi Weitong granules in the treatment of diarrhea-type irritable bowel syndrome (IBS-D);2) To explore the dosage of Qizhi Weitong Granulesin treatment of IBS-D.

Timeline

Start
2021-12-01
Primary completion
2022-08-31
Completion
2022-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Qizhi Weitong Granules Unknown 2.5 g Oral
Subject Qizhi Weitong Granules Unknown 5 g Oral